AUSTIN, Texas, Jan. 04, 2024 (GLOBE NEWSWIRE) Lumos Pharma, Inc. LUMO, a late-stage biopharmaceutical company focused on therapeutics for rare diseases,…
AUSTIN, Texas, Jan. 04, 2024 Lumos Pharma, Inc. , a late-stage biopharmaceutical company focused on therapeutics for rare diseases, has promoted Pisit “Duke” Pitukcheewanont, MD, known also.
Lumos Pharma, Inc : Lumos Pharma Announces Departure of Chief Medical Officer finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
AUSTIN, Texas, June 28, 2023 (GLOBE NEWSWIRE) Lumos Pharma, Inc. (NASDAQ:LUMO), a biopharmaceutical company advancing an oral therapeutic candidate for idiopathic Pediatric Growth Hormone Deficiency (iPGHD) through Phase 2 clinical trials, announced .